Concepedia

Lingdi Zhao

LZ

Statistics

Publications

27

Citations

653

H-Index

17

Active since

2012

Affiliations

Henan Cancer Hospital(Current)

Zhengzhou University

Xinxiang Medical University

Tianjin Medical University Cancer Institute and Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Lingdi Zhao is an author at Henan Cancer Hospital specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2012–2023

27

Publications

27

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

Wenqun Xing, Lingdi Zhao, Zheng Yan et al. · Frontiers in Immunology · 2021 · 67 citations · Full text

Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients

Shuai Wang, Xiaohong Han, Xingsheng Hu et al. · Clinica Chimica Acta · 2014 · 49 citations

, , +9

Association of Myeloid-derived Suppressor Cells and Efficacy of Cytokine-induced Killer Cell Immunotherapy in Metastatic Renal Cell Carcinoma Patients

Zibing Wang, Yong Zhang, Yuqing Liu et al. · Journal of Immunotherapy · 2013 · 47 citations

, , +15

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus

Lu Han, Jian Zhou, Keshu Zhou et al. · Journal for ImmunoTherapy of Cancer · 2020 · 44 citations · Full text

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Wenqun Xing, Lingdi Zhao, Xiaomin Fu et al. · Journal of Thoracic Disease · 2020 · 42 citations · Full text

1–5 of 27